Peter Powchik

SVP, Clinical Development, Regeneron Pharmaceuticals.

Companies

Vaxxinity, Inc.Board member Apr 4, 2022 to Oct 11, 2023¹
Regeneron PharmaceuticalsSVP, Clinical Development Oct 3, 2006 to Dec 19, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vaxxinity, Inc.225,858 shares³Jun 23, 2022

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVaxxinity, Inc., Board member
2
SEC EDGARRegeneron Pharmaceuticals, SVP, Clinical Development
3
SEC EDGARVaxxinity, Inc. shares after the filing of Jun 23, 2022